Trial Profile
Effects of TS-1 and heparin-based chemoradiation combined with MMC, CDDP as the neoadjuvant therapy on the patients with the potentially resectable pancreatic cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2012
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Heparin; Mitomycin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Feb 2012 New trial record